212 related articles for article (PubMed ID: 20810749)
21. Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB.
Wright CC; Wisner TW; Hannah BP; Eisenberg RJ; Cohen GH; Johnson DC
J Virol; 2009 Nov; 83(22):11847-56. PubMed ID: 19759132
[TBL] [Abstract][Full Text] [Related]
22. Acidic pH Mediates Changes in Antigenic and Oligomeric Conformation of Herpes Simplex Virus gB and Is a Determinant of Cell-Specific Entry.
Weed DJ; Dollery SJ; Komala Sari T; Nicola AV
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925660
[TBL] [Abstract][Full Text] [Related]
23. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.
Hubbard S; Choudhary S; Maus E; Shukla D; Swenson S; Markland FS; Tiwari V
Antivir Ther; 2012; 17(7):1319-26. PubMed ID: 22875654
[TBL] [Abstract][Full Text] [Related]
24. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.
Fan Q; Kopp S; Connolly SA; Muller WJ; Longnecker R
Sci Rep; 2017 Mar; 7():43712. PubMed ID: 28255168
[TBL] [Abstract][Full Text] [Related]
25. Common characteristics and unique features: A comparison of the fusion machinery of the alphaherpesviruses Pseudorabies virus and Herpes simplex virus.
Vallbracht M; Backovic M; Klupp BG; Rey FA; Mettenleiter TC
Adv Virus Res; 2019; 104():225-281. PubMed ID: 31439150
[TBL] [Abstract][Full Text] [Related]
26. Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts.
Petermann P; Rahn E; Thier K; Hsu MJ; Rixon FJ; Kopp SJ; Knebel-Mörsdorf D
J Virol; 2015 Sep; 89(18):9407-16. PubMed ID: 26136572
[TBL] [Abstract][Full Text] [Related]
27. Mildly Acidic pH Triggers an Irreversible Conformational Change in the Fusion Domain of Herpes Simplex Virus 1 Glycoprotein B and Inactivation of Viral Entry.
Weed DJ; Pritchard SM; Gonzalez F; Aguilar HC; Nicola AV
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003487
[TBL] [Abstract][Full Text] [Related]
28. Conformational Changes in Herpes Simplex Virus Glycoprotein C.
Gianopulos KA; Komala Sari T; Weed DJ; Pritchard SM; Nicola AV
J Virol; 2022 Aug; 96(16):e0016322. PubMed ID: 35913218
[TBL] [Abstract][Full Text] [Related]
29. Localization of the Interaction Site of Herpes Simplex Virus Glycoprotein D (gD) on the Membrane Fusion Regulator, gH/gL.
Cairns TM; Atanasiu D; Saw WT; Lou H; Whitbeck JC; Ditto NT; Bruun B; Browne H; Bennett L; Wu C; Krummenacher C; Brooks BD; Eisenberg RJ; Cohen GH
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759318
[TBL] [Abstract][Full Text] [Related]
30. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.
Tiwari V; Shukla SY; Shukla D
Antiviral Res; 2009 Oct; 84(1):67-75. PubMed ID: 19665490
[TBL] [Abstract][Full Text] [Related]
31. Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry.
Fan Q; Amen M; Harden M; Severini A; Griffiths A; Longnecker R
J Virol; 2012 Apr; 86(8):4468-76. PubMed ID: 22345445
[TBL] [Abstract][Full Text] [Related]
32. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.
Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
PLoS Pathog; 2017 Apr; 13(4):e1006352. PubMed ID: 28423057
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis.
Devadas D; Koithan T; Diestel R; Prank U; Sodeik B; Döhner K
J Virol; 2014 Nov; 88(22):13378-95. PubMed ID: 25210183
[TBL] [Abstract][Full Text] [Related]
34. Understanding HSV-1 entry glycoproteins.
Reske A; Pollara G; Krummenacher C; Chain BM; Katz DR
Rev Med Virol; 2007; 17(3):205-15. PubMed ID: 17295428
[TBL] [Abstract][Full Text] [Related]
35. αvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion.
Gianni T; Salvioli S; Chesnokova LS; Hutt-Fletcher LM; Campadelli-Fiume G
PLoS Pathog; 2013; 9(12):e1003806. PubMed ID: 24367260
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.
Antoine TE; Shukla D
Antivir Ther; 2014; 19(1):15-29. PubMed ID: 23813409
[TBL] [Abstract][Full Text] [Related]
37. Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD.
Avitabile E; Forghieri C; Campadelli-Fiume G
J Virol; 2009 Oct; 83(20):10752-60. PubMed ID: 19656900
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Herpes Simplex Virus Glycoprotein-Induced Cascade of Events Governing Cell-Cell Fusion.
Atanasiu D; Saw WT; Eisenberg RJ; Cohen GH
J Virol; 2016 Dec; 90(23):10535-10544. PubMed ID: 27630245
[TBL] [Abstract][Full Text] [Related]
39. Insertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry.
Jackson JO; Lin E; Spear PG; Longnecker R
J Virol; 2010 Feb; 84(4):2038-46. PubMed ID: 20007280
[TBL] [Abstract][Full Text] [Related]
40. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis.
Arii J; Wang J; Morimoto T; Suenaga T; Akashi H; Arase H; Kawaguchi Y
J Virol; 2010 Oct; 84(20):10773-83. PubMed ID: 20686018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]